Investors and industry observers can follow the company's update via a live audio webcast hosted on the BioMarin investor relations portal. Following the event, the company plans to maintain an archived version of the session on its website for a limited duration.
BioMarin Management Heads to Boston for Canaccord Growth Conference
BioMarin Pharmaceutical executives are set to take the stage at the Canaccord Genuity 46th Annual Growth Conference in Boston this Wednesday. The presentation, scheduled for 8:00 a.m. ET on August 12, marks a key opportunity for the San Rafael-based biotech firm to outline its progress in rare disease therapeutics.
Founded in 1997, BioMarin currently manages a portfolio of nine commercial therapies. The firm focuses on developing medicines for genetically defined conditions, leveraging its research pipeline to transition clinical and preclinical candidates into market-ready treatments.
Comments (0)
No comments yet. Be the first!